LAUREN KRITZER: Open Payments
NPI 1962150797 · COPPELL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,794 in 95 payments from 23 companies in 2025. Trend: 2023 $217 · 2024 $1,613 · 2025 $1,794
Food & beverage: $1,734Education: $60
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $247 |
| ABBVIE INC. | 13 | $202 |
| AstraZeneca Pharmaceuticals LP | 7 | $187 |
| Astellas Pharma US Inc | 6 | $172 |
| Lilly USA, LLC | 9 | $142 |
| PFIZER INC. | 10 | $141 |
| Otsuka America Pharmaceutical, Inc. | 10 | $141 |
| Amgen Inc. | 4 | $68 |
| Dexcom, Inc. | 2 | $61 |
| ViiV Healthcare Company | 2 | $60 |
Products named: REXULTI, VRAYLAR, Veozah, Wegovy, MOUNJARO, Ozempic, FARXIGA, UBRELVY.
Industry payments across TX — which companies pay providers there.
